Amaury Basse
Overview
Explore the profile of Amaury Basse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Athanasakis K, Bala C, Kokkinos A, Simonyi G, Karoliova K, Basse A, et al.
BMC Health Serv Res
. 2024 Mar;
24(1):354.
PMID: 38504302
Objective: To provide an assessment of the cost burden of obesity across a spectrum of obesity-related comorbidities (ORCs) for four countries in South-Eastern Europe (SEE). Methods: A micro-costing analysis from...
2.
Yavuz D, Akhtar O, Low K, Gras A, Gurser B, Safak Yilmaz E, et al.
Clinicoecon Outcomes Res
. 2024 Mar;
16:123-132.
PMID: 38476579
Background: Turkey currently has the highest obesity prevalence among its European counterparts. 32% and 61% of the population live with obesity and overweight, respectively. Overweight and obesity are linked to...
3.
Reitzel S, Bogelund M, Basse A, Barszczewska O, Ren H
Curr Med Res Opin
. 2023 Jul;
39(8):1055-1060.
PMID: 37415503
Objectives: The glucagon-like peptide-1 agonist semaglutide and the dual glucose-dependent insulinotropic polypeptide tirzepatide have proven to significantly reduce glucose levels in people with type 2 diabetes. However, the costs needed...
4.
Brod M, Basse A, Markert M, Pfeiffer K
Diabetes Ther
. 2019 May;
10(4):1323-1336.
PMID: 31127490
Introduction: Currently, there is limited knowledge of the healthcare resources and time needed to intensify patients with type 2 diabetes (T2D) treated with basal insulin to more complex treatment regimens....
5.
Mezquita Raya P, Blasco F, Hunt B, Martin V, Thorsted B, Basse A, et al.
Diabetes Obes Metab
. 2019 Feb;
21(6):1349-1356.
PMID: 30740861
Aim: To evaluate the long-term cost-effectiveness of fixed-ratio combination insulin degludec/liraglutide (IDegLira) versus comparator regimens for type 2 diabetes in Spain, based on real-world evidence. Materials And Methods: Clinical data...
6.
Pfeiffer K, Basse A, Lee X, Waldman L
Diabetes Ther
. 2018 Aug;
9(5):1931-1944.
PMID: 30120755
Introduction: Currently, there is limited knowledge about the experiences and challenges type 2 diabetes (T2D) patients face when intensifying from basal insulin to more complex regimens. The purpose of this...
7.
Drummond R, Baru A, Dutkiewicz M, Basse A, Tengmark B
BMJ Open Diabetes Res Care
. 2018 Jun;
6(1):e000531.
PMID: 29942526
Objective: This study aimed to build on the current clinical findings and investigate physicians' experiences and level of satisfaction in using insulin degludec/liraglutide (IDegLira) to treat patients with type 2...